System and method of trans-venous pre-aortic ganglion ablation
AssigneeEnigma Medical, Inc.
InventorsDenise Barbut, Allan Rozenberg, Axel Heinemann
Life of this patent
Estimating the term…
Abstract
A method of modulating a physiological parameter of a patient is provided. The method includes disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion trans-venously and improving the physiological parameter. The method further includes destroying a pre-aortic ganglion cell trans-venously to prevent regeneration.
Claims34
A method of modulating a physiological parameter of a patient, comprising disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion trans-venously and improving said physiological parameter.
A method of modulating a physiological parameter of a patient, comprising destroying a pre-aortic ganglion cell trans-venously to prevent regeneration.
A method of modulating a physiological parameter of a patient, comprising trans-venously denervating one or more cells within a pre-aortic ganglion and improving said physiological parameter wherein vessel spasm and dissection are avoided.
A method of modulating a physiological parameter of a patient, comprising trans-venously denervating one or more cells within a pre-aortic ganglion and improving said physiological parameter wherein deterioration of renal function is avoided.
A method of modulating a physiological parameter of a patient, comprising trans-venously denervating one or more cells within a pre-aortic ganglion and improving said physiological parameter wherein embolization from a renal artery is avoided.
A method of modulating a physiologic parameter of a patient, comprising trans-venously denervating one or more cells within a pre-aortic ganglion and improving said physiologic parameter wherein groin hematoma is avoided.
A method of modulating a physiologic parameter of a patient, comprising trans-venously denervating one or more cells within a pre-aortic ganglion and improving said physiologic parameter wherein femoral artery pseudoaneurysm is avoided.
A method of modulating a physiologic parameter of a patient, comprising trans-venously denervating one or more cells within a pre-aortic ganglion and improving said physiologic parameter wherein groin compression is not required.
Dependencies are inferred from the claim text.